Challenge of Sustainable Pricing Model

Alexander Bastian

Video Categories: Pricing

Alexander Bastian speaks about the need for a sustainable model of pricing as related to cancer treatments and drug development. He talks about indication-based pricing or tumor-based pricing—says that is compelling, but not necessarily possible in the US.
October 16, 2015

The Role of Anti-PD-1 Antibodies

Dr. Sanjiv Agarwala addresses the possibility of updating indications for Nivolumab and Pembrolizumab in the therapeutic arena.

January 30, 2014

Personalized Medicine and Drug Development/Approval

Listen as Dr Agarwala presents how developments in personalized medicine will impact and change the way drugs are developed and approved.